Author:
Coppo P,Gouilleux-Gruart V,Huang Y,Bouhlal H,Bouamar H,Bouchet S,Perrot C,Vieillard V,Dartigues P,Gaulard P,Agbalika F,Douay L,Lassoued K,Gorin N-C
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference50 articles.
1. Jaffe ES, Harris NL, Stein H, Vardiman JW . World Health Organization Classification of Tumours. Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, 2001.
2. Jaffe ES . Pathobiology of peripheral T-cell lymphomas. Hematology Am Soc Hematol Educ Program 2006, 317–322.
3. Kanavaros P, Lescs MC, Briere J, Divine M, Galateau F, Joab I et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81: 2688–2695.
4. Kanavaros P, Briere J, Emile JF, Gaulard P . Epstein-Barr virus in T and natural killer (NK) cell non-Hodgkin's lymphomas. Leukemia 1996; 10 (Suppl 2): s84–s87.
5. Bossard C, Belhadj K, Reyes F, Martin-Garcia N, Berger F, Kummer JA et al. Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood 2007; 109: 2183–2189.
Cited by
94 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献